Ferozsons Laboratories Limited (PSX:FEROZ)
Pakistan · Delayed Price · Currency is PKR 333.00
+4.84 (1.47%)
At close: Oct 15, 2026
Ferozsons Laboratories Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 23,958 | 18,857 | 15,855 | 11,457 | 9,330 | |
Revenue Growth | 27.05% | 18.93% | 38.38% | 22.80% | 5.08% |
Cost of Revenue | 13,341 | 10,895 | 9,418 | 7,252 | 5,380 |
Gross Profit | 10,617 | 7,962 | 6,436 | 4,206 | 3,950 |
Selling, General & Admin | 8,052 | 5,819 | 4,605 | 3,183 | 2,641 |
Other Operating Expenses | 154.55 | 134.79 | 241.41 | 51.41 | 79.7 |
Operating Expenses | 8,276 | 6,026 | 4,848 | 3,256 | 2,731 |
Operating Income | 2,341 | 1,935 | 1,589 | 949.17 | 1,219 |
Interest Expense | -394.47 | -550.69 | -648.39 | -295.51 | -83.29 |
Interest & Investment Income | 12.48 | 150.67 | 56.02 | 206.68 | 232.06 |
Currency Exchange Gain (Loss) | -41.93 | -48.08 | 33.35 | -478.9 | -161.84 |
Other Non Operating Income (Expenses) | -23.59 | -23.59 | -24.06 | -8.6 | -12.99 |
EBT Excluding Unusual Items | 1,893 | 1,464 | 1,006 | 372.84 | 1,193 |
Gain (Loss) on Sale of Investments | 137.02 | 67.85 | 56.11 | 12.99 | 8.69 |
Gain (Loss) on Sale of Assets | 26.97 | 24.03 | 78.51 | 28.84 | 35.11 |
Pretax Income | 2,057 | 1,555 | 1,140 | 414.67 | 1,237 |
Income Tax Expense | 829.67 | 633.75 | 384.74 | 118.43 | 447.13 |
Earnings From Continuing Operations | 1,228 | 921.71 | 755.48 | 296.24 | 789.79 |
Minority Interest in Earnings | -249.15 | -145.17 | -72.33 | -24.97 | -55.36 |
Net Income | 978.58 | 776.54 | 683.15 | 271.27 | 734.43 |
Net Income to Common | 978.58 | 776.54 | 683.15 | 271.27 | 734.43 |
Net Income Growth | 26.02% | 13.67% | 151.84% | -63.06% | -37.41% |
Shares Outstanding (Basic) | 43 | 43 | 43 | 43 | 43 |
Shares Outstanding (Diluted) | 43 | 43 | 43 | 43 | 43 |
Shares Change | - | - | - | - | - |
EPS (Basic) | 22.51 | 17.86 | 15.72 | 6.24 | 16.90 |
EPS (Diluted) | 22.51 | 17.86 | 15.72 | 6.24 | 16.90 |
EPS Growth | 26.02% | 13.67% | 151.84% | -63.06% | -37.41% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -749.6 | 771.95 | -1,079 | -2,861 | -1,457 |
Free Cash Flow Per Share | -17.25 | 17.76 | -24.83 | -65.82 | -33.52 |
Dividend Per Share | 5.500 | 4.000 | 3.000 | - | 4.167 |
Dividend Growth | 37.50% | 33.33% | - | - | -50.00% |
Gross Margin | 44.32% | 42.22% | 40.60% | 36.71% | 42.34% |
Operating Margin | 9.77% | 10.26% | 10.02% | 8.28% | 13.07% |
Profit Margin | 4.08% | 4.12% | 4.31% | 2.37% | 7.87% |
Free Cash Flow Margin | -3.13% | 4.09% | -6.81% | -24.97% | -15.62% |
EBITDA | 3,337 | 2,851 | 2,106 | 1,421 | 1,640 |
EBITDA Margin | 13.93% | 15.12% | 13.28% | 12.40% | 17.58% |
D&A For EBITDA | 996.55 | 915.61 | 517.09 | 471.85 | 420.85 |
EBIT | 2,341 | 1,935 | 1,589 | 949.17 | 1,219 |
EBIT Margin | 9.77% | 10.26% | 10.02% | 8.28% | 13.07% |
Effective Tax Rate | 40.33% | 40.74% | 33.74% | 28.56% | 36.15% |
Advertising Expenses | 1,149 | 762.88 | 712.1 | 385.33 | 301.07 |